Skip to main content

Advertisement

ADVERTISEMENT

Case Study

Case Study
05/02/2015

Rakesh Gopinathannair, MD, MA, FHRS, Director of Cardiac Electrophysiology, Assistant Professor of Medicine, Division of Cardiovascular Medicine, Section of Electrophysiology, University of Louisville, Louisville, Kentucky

Rakesh Gopinathannair, MD, MA, FHRS, ...
In this patient with pre-existing ischemic heart disease, two different arrhythmias — persistent atrial flutter and frequent PVCs — contributed to the development of cardiomyopathy and heart failure.
In this patient with pre-existing ischemic heart disease, two different arrhythmias — persistent atrial flutter and frequent PVCs — contributed to the development of cardiomyopathy and heart failure.
In this patient with...
05/02/2015
EP Lab Digest

Advertisement

Case Study
05/02/2015

J. Jenkins Thompson, MD, Jayanthi N. Koneru, MBBS, Kenneth A. Ellenbogen, MD, Pauley Heart Center, VCU School of Medicine, Richmond, Virginia

J. Jenkins Thompson, MD, Jayanthi N. ...
Recently, additional investigational percutaneous therapies have been developed for patients with refractory heart failure and ischemic cardiomyopathy.
Recently, additional investigational percutaneous therapies have been developed for patients with refractory heart failure and ischemic cardiomyopathy.
Recently, additional...
05/02/2015
EP Lab Digest
Case Study
05/02/2015

Snigdha Kola, MD, Indrajeet Mahata, MD, Abraham G. Kocheril, MD, FACC, FACP, FHRS, University of Illinois College of Medicine, Urbana-Champaign, Illinois

Snigdha Kola, MD, Indrajeet Mahata, M...
A clinically important but infrequent consequence of flecainide toxicity is its organization of atrial fibrillation into atrial flutter, as seen in this case. With resolution of the toxicity, the atrial flutter converted back to AF.
A clinically important but infrequent consequence of flecainide toxicity is its organization of atrial fibrillation into atrial flutter, as seen in this case. With resolution of the toxicity, the atrial flutter converted back to AF.
A clinically important but...
05/02/2015
EP Lab Digest
Case Study
03/03/2015

James A. Reiss, MD, MPH, FACC, PeaceHealth Southwest Medical Center, Vancouver, Washington

James A. Reiss, MD, MPH, FACC, PeaceH...
James A. Reiss, MD, MPH, FACC, presents a recent patient who successfully underwent PVI using Arctic Front.
James A. Reiss, MD, MPH, FACC, presents a recent patient who successfully underwent PVI using Arctic Front.
James A. Reiss, MD, MPH,...
03/03/2015
EP Lab Digest

Advertisement

Case Study
02/01/2015

Nadim Khan, MD, Kimberly Clawson, RN, RCES, Fitzalbert Martin, CVT, Renee Dunfee, CVT, RCIS, Karma Nguyen, RN, Tharen Leesch, CVT, RCIS, RCES 

Florida Hospital Wesley Chapel, 

Wesley Chapel, Florida

Nadim Khan, MD, Kimberly Clawson, RN,...
Nadim Khan, MD, and colleagues provide a review and brief case of Lown-Ganong-Levine syndrome, a paroxysmal supraventricular tachycardia that is rarely seen.
Nadim Khan, MD, and colleagues provide a review and brief case of Lown-Ganong-Levine syndrome, a paroxysmal supraventricular tachycardia that is rarely seen.
Nadim Khan, MD, and colleagues...
02/01/2015
EP Lab Digest
Case Study
12/29/2014

Adam Zivin, MD, FACC, FHRS
Cardiac Electrophysiology Lab
Swedish Medical Center
Seattle, Washington

Adam Zivin, MD, FACC, FHRS Cardiac El...
Adam Zivin, MD, FACC, FHRS, discusses how catheter ablation of Mahaim-type accessory pathways can be difficult due to challenges with accurate mapping of AP location.
Adam Zivin, MD, FACC, FHRS, discusses how catheter ablation of Mahaim-type accessory pathways can be difficult due to challenges with accurate mapping of AP location.
Adam Zivin, MD, FACC, FHRS,...
12/29/2014
EP Lab Digest
Case Study
12/29/2014

Payam Safavi-Naeini, MD, Mohammad Saeed, MD, Abdi Rasekh, MD, MD, Ali Massumi, Mehdi Razavi, MD
Department of Cardiology, Texas Heart Institute at Baylor St. Luke's Medical Center, Houston, Texas

Payam Safavi-Naeini, MD, Mohammad Sae...
In this article, the authors present 2 cases of ARVC/D that were admitted to their center for evaluation and treatment of drug-refractory ventricular tachycardia and recurrent implantable cardioverter-defibrillator shocks.
In this article, the authors present 2 cases of ARVC/D that were admitted to their center for evaluation and treatment of drug-refractory ventricular tachycardia and recurrent implantable cardioverter-defibrillator shocks.
In this article, the authors...
12/29/2014
EP Lab Digest

Advertisement

Case Study
12/29/2014

Bhavya Trivedi, MD, PhD
Director, Pediatric and Adult Congenital Electrophysiology
Florida Hospital for Children
Florida Hospital Cardiovascular Institute, Orlando, Florida

Bhavya Trivedi, MD, PhD Director, Ped...
Dr Trivedi describes a case in which an infant with congenital heart disease and other medical conditions underwent successful ablation of incessant atrial arrhythmias that could not be controlled with medical management.
Dr Trivedi describes a case in which an infant with congenital heart disease and other medical conditions underwent successful ablation of incessant atrial arrhythmias that could not be controlled with medical management.
Dr Trivedi describes a case in...
12/29/2014
EP Lab Digest
Case Study
11/04/2014

Lou Mastrine, DO1, Yisachar Jesse Greenberg, MD, FACC, FHRS2, Felix Yang, MD, FACC, FHRS, CCDS2, 1New York Methodist Hospital, Brooklyn, New York; 2Maimonides Medical Center, Brooklyn, New York

Lou Mastrine, DO1, Yisachar Jesse Gre...
The PentaRay® NAV (Biosense Webster, Inc., a Johnson & Johnson company) (Figure 1) became available in 2012 and was recommended for use in cases of atrial tachycardia, ventricular tachycardia, and complex fractionated electrograms in...
The PentaRay® NAV (Biosense Webster, Inc., a Johnson & Johnson company) (Figure 1) became available in 2012 and was recommended for use in cases of atrial tachycardia, ventricular tachycardia, and complex fractionated electrograms in...
The PentaRay® NAV (Biosense...
11/04/2014
EP Lab Digest
Case Study
07/31/2014

Alyssa M. Feldman, MS, Daniel Kersten, Todd J. Cohen, MD, Department of Medicine at Winthrop University Hospital, Mineola, New York

Alyssa M. Feldman, MS, Daniel Kersten...
Pulmonary embolism (PE) is a relatively uncommon but serious complication of radiofrequency catheter ablation. A better understanding of PE risk factors and the proactive administration of thromboprophylaxis in high-risk patients may help...
Pulmonary embolism (PE) is a relatively uncommon but serious complication of radiofrequency catheter ablation. A better understanding of PE risk factors and the proactive administration of thromboprophylaxis in high-risk patients may help...
Pulmonary embolism (PE) is a...
07/31/2014
EP Lab Digest

Advertisement

Advertisement